{
  "id": 1570311,
  "title": "Earnings call transcript: Precipio tops $7 million in Q2 2025 as growth turns profitable",
  "url": "https://urgent.news/2026/08/17/earnings-call-transcript-precipio-tops-7-million-in-q2-2025-as-growth",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-17T21:50:21.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-precipio-tops-7-million-in-q2-2025-as-growth-turns-profitable-93CH-4864034"
  },
  "original_language": "en",
  "account": null,
  "summary": "Precipio Diagnostics reported a record $7.0 million in second-quarter revenue, marking a 22.8% increase from the previous year. The company returned to positive adjusted EBITDA and generated $700,000 in operating cash flow. Management highlighted the growth of the Rapid AML Panel and a widening commercial pipeline as key drivers of the strong performance. The pathogen business revenue rose to $6.1 million, while product revenue increased to $900,000, accounting for 12.9% of total sales. This quarter was a milestone as Precipio became the first to exceed $7 million in revenue, with a market capitalization of $42.84 million and a 62.6% total return over the past year.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Earnings call transcript: Streamex Q2 2026 revenue debut misses estimates as shares slide",
        "url": "https://urgent.news/2026/08/17/earnings-call-transcript-streamex-q2-2026-revenue-debut-misses",
        "published": "2026-08-17T21:40:37.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}